Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Michael Darmon, MD, PhD, of Saint-Louis University Hospital, Paris, France discusses the importance of the early admission of CAR-T patients to the ICU if they are displaying any signs of acute illness, in order to prevent further health decline. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.